| Dr Dwayne C Miller, MD | |
|
10201 Highway 16, Comanche, TX 76442-4462 | |
| (254) 879-4910 | |
| (254) 879-4990 |
| Full Name | Dr Dwayne C Miller |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 39 Years |
| Location | 10201 Highway 16, Comanche, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316957574 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | H0638 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Encompass Health Home Health | Abilene, TX | Home health agency |
| Kindred At Home | Brownwood, TX | Home health agency |
| Stephens Health Care Inc | Stephenville, TX | Home health agency |
| Alpha Omega Hospice Lp | Hurst, TX | Hospice |
| Comanche County Medical Center | Comanche, TX | Hospital |
| Deleon Nursing And Rehabilitation | De leon, TX | Nursing home |
| Western Hills Healthcare Residence | Comanche, TX | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Comanche County Medical Center Company | 3678753357 | 17 |
| Texas Outpatient And Infusion Center | 6305229204 | 3 |
| Dfw Diabetic Relief Llc | 7214382738 | 2 |
News Archive
Cellectis S.A., the French genome engineering specialist, has announced that the European Patent Office has today upheld European Patent EP 1 485 475 owned by Cellectis and relating to the invention of engineering methods for meganucleases. This method is based on the genetic fusion of meganuclease modules to obtain hybrid meganucleases.
A report issued by the Program on International Health and Human Rights at the Harvard School of Public Health proposes a new research agenda to address the sexual and reproductive health and rights of HIV-positive women.
People with psychosis often develop an addiction disorder: almost one in two patients with schizophrenia are affected once during their lifetime. Patients with a dual diagnosis mostly have a poorer prognosis, and their disorder often becomes chronic.
Prostate cancer patients who are treated with a combination of hormone therapy and radiation have a substantially improved chance of survival compared to patients who do not receive radiation, according to interim results of the largest randomized study of its kind presented at the plenary session, November 1, 2010, at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO).
A cancer diagnosis can be a life-changing event. Many questions arise, with one of the first being, "Where should I be treated?" Patients diagnosed with rare cancers may have difficulty finding a physician knowledgeable in treating their type of cancer.
› Verified 7 days ago
| Entity Name | Comanche County Medical Center Company |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346544616 PECOS PAC ID: 3678753357 Enrollment ID: O20110825000076 |
News Archive
Cellectis S.A., the French genome engineering specialist, has announced that the European Patent Office has today upheld European Patent EP 1 485 475 owned by Cellectis and relating to the invention of engineering methods for meganucleases. This method is based on the genetic fusion of meganuclease modules to obtain hybrid meganucleases.
A report issued by the Program on International Health and Human Rights at the Harvard School of Public Health proposes a new research agenda to address the sexual and reproductive health and rights of HIV-positive women.
People with psychosis often develop an addiction disorder: almost one in two patients with schizophrenia are affected once during their lifetime. Patients with a dual diagnosis mostly have a poorer prognosis, and their disorder often becomes chronic.
Prostate cancer patients who are treated with a combination of hormone therapy and radiation have a substantially improved chance of survival compared to patients who do not receive radiation, according to interim results of the largest randomized study of its kind presented at the plenary session, November 1, 2010, at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO).
A cancer diagnosis can be a life-changing event. Many questions arise, with one of the first being, "Where should I be treated?" Patients diagnosed with rare cancers may have difficulty finding a physician knowledgeable in treating their type of cancer.
› Verified 7 days ago
| Entity Name | Texas Outpatient & Infusion Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730839846 PECOS PAC ID: 6305229204 Enrollment ID: O20220810000373 |
News Archive
Cellectis S.A., the French genome engineering specialist, has announced that the European Patent Office has today upheld European Patent EP 1 485 475 owned by Cellectis and relating to the invention of engineering methods for meganucleases. This method is based on the genetic fusion of meganuclease modules to obtain hybrid meganucleases.
A report issued by the Program on International Health and Human Rights at the Harvard School of Public Health proposes a new research agenda to address the sexual and reproductive health and rights of HIV-positive women.
People with psychosis often develop an addiction disorder: almost one in two patients with schizophrenia are affected once during their lifetime. Patients with a dual diagnosis mostly have a poorer prognosis, and their disorder often becomes chronic.
Prostate cancer patients who are treated with a combination of hormone therapy and radiation have a substantially improved chance of survival compared to patients who do not receive radiation, according to interim results of the largest randomized study of its kind presented at the plenary session, November 1, 2010, at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO).
A cancer diagnosis can be a life-changing event. Many questions arise, with one of the first being, "Where should I be treated?" Patients diagnosed with rare cancers may have difficulty finding a physician knowledgeable in treating their type of cancer.
› Verified 7 days ago
| Entity Name | Dfw Diabetic Relief Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265120240 PECOS PAC ID: 7214382738 Enrollment ID: O20231018001282 |
News Archive
Cellectis S.A., the French genome engineering specialist, has announced that the European Patent Office has today upheld European Patent EP 1 485 475 owned by Cellectis and relating to the invention of engineering methods for meganucleases. This method is based on the genetic fusion of meganuclease modules to obtain hybrid meganucleases.
A report issued by the Program on International Health and Human Rights at the Harvard School of Public Health proposes a new research agenda to address the sexual and reproductive health and rights of HIV-positive women.
People with psychosis often develop an addiction disorder: almost one in two patients with schizophrenia are affected once during their lifetime. Patients with a dual diagnosis mostly have a poorer prognosis, and their disorder often becomes chronic.
Prostate cancer patients who are treated with a combination of hormone therapy and radiation have a substantially improved chance of survival compared to patients who do not receive radiation, according to interim results of the largest randomized study of its kind presented at the plenary session, November 1, 2010, at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO).
A cancer diagnosis can be a life-changing event. Many questions arise, with one of the first being, "Where should I be treated?" Patients diagnosed with rare cancers may have difficulty finding a physician knowledgeable in treating their type of cancer.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Dwayne C Miller, MD 6610 Hwy 2318, Comanche, TX 76442-6622 Ph: (254) 879-4910 | Dr Dwayne C Miller, MD 10201 Highway 16, Comanche, TX 76442-4462 Ph: (254) 879-4910 |
News Archive
Cellectis S.A., the French genome engineering specialist, has announced that the European Patent Office has today upheld European Patent EP 1 485 475 owned by Cellectis and relating to the invention of engineering methods for meganucleases. This method is based on the genetic fusion of meganuclease modules to obtain hybrid meganucleases.
A report issued by the Program on International Health and Human Rights at the Harvard School of Public Health proposes a new research agenda to address the sexual and reproductive health and rights of HIV-positive women.
People with psychosis often develop an addiction disorder: almost one in two patients with schizophrenia are affected once during their lifetime. Patients with a dual diagnosis mostly have a poorer prognosis, and their disorder often becomes chronic.
Prostate cancer patients who are treated with a combination of hormone therapy and radiation have a substantially improved chance of survival compared to patients who do not receive radiation, according to interim results of the largest randomized study of its kind presented at the plenary session, November 1, 2010, at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO).
A cancer diagnosis can be a life-changing event. Many questions arise, with one of the first being, "Where should I be treated?" Patients diagnosed with rare cancers may have difficulty finding a physician knowledgeable in treating their type of cancer.
› Verified 7 days ago
Jeffrey Clark Hutchins, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10201 Highway 16, Comanche, TX 76442 Phone: 254-879-4900 | |
Dr. Stephen Howard Dickey, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10201 Highway 16, Comanche, TX 76442 Phone: 254-879-4910 Fax: 254-879-4991 | |
Dr. Richard Wayne Byrd, M.D. Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 201 Valley Forge St, Comanche, TX 76442 Phone: 325-356-5595 Fax: 325-356-3809 | |
Dr. Guyle P Donham, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10201 Highway 16, Comanche, TX 76442 Phone: 254-879-4910 Fax: 254-879-4991 | |
Dr. Garry Todd Davis, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10201 Highway 16, Comanche, TX 76442 Phone: 254-879-4910 Fax: 254-879-4991 | |
Dr. Peter G. Fagan, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 10201 Highway 16, Comanche, TX 76442 Phone: 254-879-4900 |